Nabta Health has closed a $2 million pre-Series A funding round, bringing its total funding to $4.5 million. The UAE-based company provides women’s healthcare through a hybrid model combining digital, at-home, and in-clinic care powered by AI.
The funding will support expansion across the Middle East and Africa, introduction of new diagnostic and at-home testing pathways, and strengthening of clinical infrastructure through hospital partnerships. Nabta will also deepen partnerships with employers, insurers, and healthcare providers.
“This investment validates our vision – that women’s health in the region can be reimagined through an AI-powered, hybrid care model that meets women where they are, respects cultural context and delivers measurable outcomes,” said Sophie Smith, Founder and CEO of Nabta Health. “We are now looking to accelerate our growth so that more women and employers benefit from what we believe is the future of women-centred health: affordable, mobile-first, and engineered for sovereignty.”
The company launched a Women’s Health Centre of Excellence in partnership with Clemenceau Medical Center Hospital Dubai and expanded its corporate health solutions across the region.
“For employers and insurers in the region, addressing the women’s health gap is not just a moral imperative; it is a business and productivity one,” Smith said. “With this funding, we will drive scale, deepen impact and prepare for the next chapter of growth.”
“The closing of this Pre-Series A round is confirmation that Nabta Health is being increasingly recognised in the region as a key enabler of measurably better women’s health,” said Iain McMillan, Chair of Nabta Health. “The business has steadily gained traction and grown its customer base throughout 2025.”
